Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization.

Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Abstract Text:

    pamela m kimballPamela M Kimball,angela owensAngela Owens,eric gibneyEric Gibney,pamela m kimballPamela M Kimball,angela owensAngela Owens,eric gibneyEric Gibney,pamela m kimballPamela M Kimball,angela owensAngela Owens,eric gibneyEric Gibney,

    Despite the success of intravenous immunoglobulin (IVIg) desensitization to reduce anti-human leukocyte antigen antibodies, its high failure rate and expense limit its usefulness. We speculated that quantitation of alloantibody concentration could allow early identification of IVIg resistant patients. Patients were described as nonresponders (n=3) or responders (n=8). Panel reactive antibodies (PRA) were determined using Flowbeads and concentration calculated as molecules of equivalent soluble fluorochrome (MESF). PRA was equivalent between nonresponders and responders before (97+/-3% vs. 76+/-20%, P=NS) and after 3 IVIg/plasmapheresis (PP) treatments but lower among responders at end-of-treatment (76+/-20% vs. 44+/-15%, P<0.01). In contrast, pretreatment MESFs were higher (333,640+/-241,352 vs. 38,741+/-5,133, P=0.006) among nonresponders than responders. During treatment, MESFs decreased (P<0.05) in 0 of 3 nonresponders vs. 8 of 8 responders. Final MESFs were higher among nonresponders than responders. We report that quantitation of MESFs allows early identification of IVIg/PP resistant patients. This sensitive and inexpensive technique should allow more effective patient selection and reduce the costs associated with desensitization.

    Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Publishing Authors By Initials

    pm kimballPM Kimball,a owensA Owens,e gibneyE Gibney,pm kimballPM Kimball,a owensA Owens,e gibneyE Gibney,pm kimballPM Kimball,a owensA Owens,e gibneyE Gibney,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Transplantation

    VOLUME: 84

    Page Numbers: 1540-3

    Journal Abbreviation: Transplantation

    ISSN: 0041-1337

    DAY: 15

    MONTH: Dec

    YEAR: 2007

    Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 132144

    Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization.

    AFFILIATION: Department of Transplant Surgery, Virginia Commonwealth University Hospital, Richmond, VA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Transplantation

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Quantitation of alloantibody concentration can predict patient sensitivity to intravenous immunoglobulin desensitization Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News